Skip to main content

Table 2 The associations of NNMT expression with OS in TCGA dataset

From: Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer

Variables

Number of patients

Univariate analysis

Multivariate analysis

HR (95%CI)

P value

HR (95%CI)

P value

Age

462

1.024 (1.013–1.036)

< 0.001

1.022 (1.010–1.034)

< 0.001

Stage

  

0.001

 

0.004

 Early

33

1

 

1

 

 Late

429

3.478 (1.639–7.381)

 

3.044 (1.415–6.550)

 

Grade

  

0.048

 

0.269

 Low

57

1

 

1

 

 High

405

1.438 (1.003–2.063)

 

1.230 (0.852–1.774)

 

Debulking

  

0.030

 

0.304

 Optimal

344

1

 

1

 

 Suboptimal

118

1.353 (1.030–1.776)

 

1.157 (0.876–1.528)

 

NNMT expression

  

0.039

 

0.051

 Low

415

1

 

1

 

 High

47

1.552 (1.022–2.357)

 

1.517 (0.998–2.306)